Pharmaceuticals Stocks - List of Pharmaceuticals Sector Stocks in India

Name	LTP	Change %	Volume	Market Cap (Cr.)	Day Range	52 Week High	52 Week Low
SUN PHARMACEUTICAL INDUSTRIES	₹1,787.40	-0.91%	20,36,801	₹4,18,660.00	₹1764.20 - ₹1815.50	₹1,960.35	₹1,377.20
DIVIS LABORATORIES	₹6,012.50	-3.27%	9,64,571	₹1,56,400.80	₹5964.50 - ₹6285.00	₹6,308.50	₹3,724.00
CIPLA	₹1,525.90	-1.66%	13,53,813	₹1,22,039.00	₹1513.50 - ₹1566.70	₹1,702.05	₹1,317.25
TORRENT PHARMACEUTICALS	₹3,240.00	-2.56%	3,30,175	₹1,10,150.50	₹3168.80 - ₹3349.10	₹3,590.70	₹2,519.95
MANKIND PHARMA	₹2,557.50	-1.6%	4,59,518	₹1,06,791.80	₹2525.00 - ₹2642.20	₹3,054.80	₹1,901.05
DR. REDDY'S LABORATORIES	₹1,174.80	-2.14%	12,86,573	₹97,960.04	₹1159.70 - ₹1210.50	₹1,421.49	₹1,020.00
LUPIN	₹2,019.60	-4.02%	7,25,961	₹91,733.05	₹2011.20 - ₹2124.90	₹2,402.90	₹1,493.30
ZYDUS LIFESCIENCES	₹859.65	-2.34%	10,90,283	₹85,061.99	₹858.00 - ₹882.35	₹1,324.30	₹795.00
AUROBINDO PHARMA	₹1,220.10	-3%	7,80,001	₹69,765.89	₹1210.00 - ₹1268.90	₹1,592.00	₹1,010.00
ABBOTT INDIA	₹29,740.00	-1.06%	5,704	₹65,692.22	₹29430.00 - ₹30295.00	₹31,898.95	₹25,200.00

Name

LTP

Change %

Volume

Market Cap (Cr.)

Day Range

52 Week High

52 Week Low

SUN PHARMACEUTICAL INDUSTRIES

₹1,787.40

-0.91%

20,36,801

₹4,18,660.00

₹1764.20 - ₹1815.50

₹1,960.35

₹1,377.20

DIVIS LABORATORIES

₹6,012.50

-3.27%

9,64,571

₹1,56,400.80

₹5964.50 - ₹6285.00

₹6,308.50

₹3,724.00

CIPLA

₹1,525.90

-1.66%

13,53,813

₹1,22,039.00

₹1513.50 - ₹1566.70

₹1,702.05

₹1,317.25

TORRENT PHARMACEUTICALS

₹3,240.00

-2.56%

3,30,175

₹1,10,150.50

₹3168.80 - ₹3349.10

₹3,590.70

₹2,519.95

MANKIND PHARMA

₹2,557.50

-1.6%

4,59,518

₹1,06,791.80

₹2525.00 - ₹2642.20

₹3,054.80

₹1,901.05

DR. REDDY'S LABORATORIES

₹1,174.80

-2.14%

12,86,573

₹97,960.04

₹1159.70 - ₹1210.50

₹1,421.49

₹1,020.00

LUPIN

₹2,019.60

-4.02%

7,25,961

₹91,733.05

₹2011.20 - ₹2124.90

₹2,402.90

₹1,493.30

ZYDUS LIFESCIENCES

₹859.65

-2.34%

10,90,283

₹85,061.99

₹858.00 - ₹882.35

₹1,324.30

₹795.00

AUROBINDO PHARMA

₹1,220.10

-3%

7,80,001

₹69,765.89

₹1210.00 - ₹1268.90

₹1,592.00

₹1,010.00

ABBOTT INDIA

₹29,740.00

-1.06%

5,704

₹65,692.22

₹29430.00 - ₹30295.00

₹31,898.95

₹25,200.00

FAQs

What are pharmaceutical stocks?

Pharmaceutical stocks represent shares of companies engaged in the development and manufacturing of medicines, vaccines and healthcare products. These firms focus on creating treatments for a wide range of medical conditions, with their stock performance impacted by factors such as clinical trial outcomes, regulatory approvals and evolving global healthcare trends.

How to invest in pharmaceutical stocks?

You can invest in pharmaceutical sector stocks through online trading platforms like Upstox:

Open an account: Sign up on Upstox and complete KYC verification.
Deposit funds: Add money to your trading account.
Research companies: Use stock screening tools to analyse pharmaceutical companies.
Purchase shares: Place a buy order for the stocks that align with your investment goals.
Monitor portfolio: Track stock performance and make necessary adjustments.

What are the risks of investing in pharmaceutical stocks?

Pharmaceutical stocks face risks such as regulatory challenges, high R&D costs, patent expirations and competition from generic drug manufacturers. Geopolitical factors and drug pricing policies can also impact profitability.

Who should invest in pharmaceutical stocks?

Pharmaceutical stocks can be a good option for investors seeking long-term growth and stability, as the healthcare sector remains vital regardless of economic fluctuations. Established pharmaceutical giants offer consistent performance, while biotech firms and emerging companies may present higher growth potential.

What are the benefits of investing in pharmaceutical stocks?

Investing in pharmaceutical sector stocks offers portfolio diversification by adding exposure to the defensive healthcare sector, which tends to remain stable even during economic downturns. Many established pharmaceutical companies offer regular dividend payouts, making them attractive for income-focused investors.

Which is the largest Pharmaceuticals sector company by Market Cap?

Largest Pharmaceuticals sector company is Sun Pharmaceutical Industries Ltd with a market capitalization of ₹418660.00.

Who are top gainers in Pharmaceuticals sector?

Today's Top gainers in Pharmaceuticals & Drugs sector are:

Onyx Biotec Ltd (7.61%)

Saroja Pharma Industries India Ltd (6.15%)

Bafna Pharmaceuticals Ltd (4.65%)

Vineet Laboratories Ltd (1.44%)

Ortin Global Ltd (1.32%)

Who are top losers in Pharmaceuticals sector?

Today's Top losers in Pharmaceuticals sector are:

SMS Lifesciences India Ltd (-8.02%)

Wanbury Ltd (-7.58%)

IND Swift Laboratories Ltd (-6.17%)

Neuland Laboratories Ltd (-5.96%)

Shilpa Medicare Ltd (-5.67%)

Which are most active stocks in Pharmaceuticals sector?

Most active stocks in Pharmaceuticals sector are:

Morepen Laboratories Ltd Vol: 16859638

Laurus Labs Ltd Vol: 7085561

Biocon Ltd Vol: 4326450

Jagsonpal Pharmaceuticals Ltd Vol: 4131662

Piramal Pharma Ltd Vol: 3966837

Upstox Securities Pvt. Ltd.: SEBI Registration No. INZ000315837 | NSE TM Code: 13942 | BSE TM Code: 6155 | CDSL Reg No.: IN-DP-761-2024 | CIN: U65100DL2021PTC376860 | Compliance Officer: Mr. Kapil Jaikalyani. Tel No.: (022) 24229920. Email ID: compliance@upstox.com | Registered Address: 809, New Delhi House, Barakhamba Road, Connaught Place, New Delhi - 110001 | RKSV Commodities India Pvt. Ltd.: SEBI Registration No.: INZ000015837 | MCX TM Code: 46510 | CIN: U74900DL2009PTC189166 | Compliance Officer: Mr. Amit Lalan. Tel No.: (022) 24229920. Email ID: compliance@rksv.in | Registered Address: 807, New Delhi House, Barakhamba Road, Connaught Place, New Delhi - 110001. Correspondence Address: 30th Floor, Sunshine Tower, Senapati Bapat Marg, Dadar (West), Mumbai - 400013. | For any complaints, email at complaints@upstox.com and complaints.mcx@upstox.com.

Procedure to file a complaint on SEBI SCORES: Register on the SCORES portal. Mandatory details for filing complaints on SCORES include: Name, PAN, Address, Mobile Number, and E-mail ID. Benefits include effective communication and speedy redressal of grievances. Please ensure you carefully read the Risk Disclosure Document as prescribed by SEBI, along with our Terms of Use and Privacy Policy.

Upstox Securities Private Limited is a wholly owned subsidiary of RKSV Securities India Private Limited and RKSV Commodities India Private Limited is an associate of RKSV Securities India Private Limited.

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing.
*Brokerage will not exceed the SEBI prescribed limit.

Risk disclosures on derivatives -

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Mutual Funds: Top rated funds do not constitute any advice. Research data is powered by Morningstar. Please read the offer documents carefully before investing. Upstox shall not accept any liability arising out of your investments.
These are not Exchange traded products, and the Member is just acting as distributor. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism.

Insurance: RKSV SECURITIES INDIA PRIVATE LIMITED ("Upstox") with registered office at 807, New Delhi House Barakhamba Road Connaught Place, New Delhi, Delhi-110001, Delhi (CIN: U74900DL2009PTC189166) is a Corporate Agent registered with Insurance Regulatory and Development Authority of India (IRDAI) (Category: Composite, IRDAI Regn No.-: CA0918 valid till 05-03-2027). Insurance is underwritten by the respective insurance companies and not by Upstox. Purchase by Upstox’s customer of any insurance products is purely voluntary, and is not linked to availment of any other facility from Upstox. For more details on risk factors and terms and conditions of insurance products, please read the sales brochure of insurance products carefully before concluding a sale. Tax benefits are subject to amendments in tax laws from time to time.

Email ID or any other mode to reach out:

Email ID: insurancesupport@rksv.in

Bima Bharosa Portal: https://bimabharosa.irdai.gov.in/

IRDAI: https://irdai.gov.in/

Insurance Ombudsman: https://www.cioins.co.in/

BEWARE OF SPURIOUS PHONE CALLS AND FICTITIOUS/FRAUDULENT OFFERS

IRDAI is not involved in activities like selling insurance policies, announcing bonuses, or investing premiums. Public receiving such phone calls are requested to lodge a police complaint.

Attention Investors: As per NSE circular dated July 6, 2022, BSE circular dated July 6, 2022, MCX circular dated July 11, 2022 investors are cautioned to abstain them from dealing in any schemes of unauthorised collective investments/portfolio management, indicative/ guaranteed/fixed returns / payments etc. Investors are further cautioned to avoid practices like:
a) Sharing i) trading credentials – login id & passwords including OTP’s., ii) trading strategies, iii) position details.
b) Trading in leveraged products /derivatives like Options without proper understanding, which could lead to losses.
c) Writing/ selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks
d) Dealing in unsolicited tips through like Whatsapp, Telegram, Instagram, YouTube, Facebook, SMS, calls, etc.
e) Trading / Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.

Kindly, read the Advisory Guidelines For Investors as prescribed by the Exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client’s assets : Advisory Guidelines For Investors

Kindly, read the advisory as prescribed by the Exchange with reference to their circular dated January 14, 2022 regarding Updation of mandatory KYC fields by March 31, 2022: KYC Updation

Attention Investors: Prevent unauthorised transactions in your Demat account by updating your mobile number with your depository participant. Receive alerts on your registered mobile number for debit and other important transactions in your Demat account directly from CDSL on the same day. Prevent unauthorised transactions in your Trading account by updating your mobile numbers/email addresses with your stock brokers. Receive information on your transactions directly from the Exchange on your mobile/email at the end of the day. Issued in the interest of investors. KYC is a one-time exercise while dealing in securities markets - once KYC is done through a SEBI-registered intermediary (broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. As a business, we don’t give stock tips and have not authorised anyone to trade on behalf of others. If you find anyone claiming to be part of Upstox or RKSV and offering such services, please send us an email at complaints@upstox.com and complaints.mcx@upstox.com.

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account. Stockbrokers can accept securities as margin from their clients only by way of a pledge in the depository system w.e.f. 1st September 2020.
Update your email ID and mobile number with your stockbroker/depository participant and receive an OTP directly from the depository on your registered email ID and/or mobile number to create a pledge.
Check your securities/mutual funds/bonds in the Consolidated Account Statement (CAS) issued by NSDL/CDSL every month.

Attention Investors: SEBI has established an Online Dispute Resolution Portal (ODR Portal) for resolving disputes in the Indian Securities Market. This circular streamlines the existing dispute resolution mechanism, offering online conciliation and arbitration, benefiting investors and listed companies. https://www.sebi.gov.in/legal/circulars/jul-2023/online-resolution-of-disputes-in-the-indian-securities-market_74794.html ODR portal for Investors - https://smartodr.in/login

Attention Investors: Clearing Corporation has provided a web based facility that allows clients to view their disaggregated collateral placed. Please access them via following links: